Description

7-[3-[[2-(3,5-Dihydroxyphenyl)-2-Hydroxyethyl]Amino]-2-Hydroxypropyl]Theophyline is a specialized theophylline derivative, a xanthine alkaloid, designed for advanced pharmaceutical research and development. This compound matters for its potential as a key intermediate or active pharmaceutical ingredient (API) in creating novel bronchodilator and anti-inflammatory therapeutics. Pharmaceutical companies and advanced research institutions need it for developing next-generation treatments targeting respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD).

Application

• Pharmaceutical Intermediate: Primary use as a critical building block in the synthesis of novel xanthine-based bronchodilator drugs.
• Active Pharmaceutical Ingredient (API) Research: Serves as a candidate molecule for developing new therapeutic agents for respiratory diseases.
• Biochemical Research: Used in pharmacological studies to investigate adenosine receptor antagonism and phosphodiesterase (PDE) inhibition mechanisms.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and validation.
• Preclinical Development: Utilized in animal model studies to assess the efficacy and pharmacokinetics of new respiratory formulations.

Basic Information

Product Name	7-[3-[[2-(3,5-Dihydroxyphenyl)-2-Hydroxyethyl]Amino]-2-Hydroxypropyl]Theophyline
CAS No.	62401-99-4
Molecular Formula	C₁₉H₂₅N₅O₆
Molecular Weight	419.43 g/mol
Synonyms	1,3-Dimethyl-7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]-2-hydroxypropyl]-3,7-dihydro-1H-purine-2,6-dione; 7-[3-[[2-(3,5-Dihydroxyphenyl)-2-hydroxyethyl]amino]-2-hydroxypropyl]-1,3-dimethylxanthine; Theophylline derivative with resorcinol; 3,7-Dihydro-1,3-dimethyl-7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]-2-hydroxypropyl]-1H-purine-2,6-dione; 62401-99-4
EINECS	Contact for details

Quality Control

Our 7-[3-[[2-(3,5-Dihydroxyphenyl)-2-Hydroxyethyl]Amino]-2-Hydroxypropyl]Theophyline is manufactured under strict quality management systems. The product undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via IR and NMR spectroscopy, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 2.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 1.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.